Industry news that matters to you.  Learn more

GE, J&J Deal Pairs Two Alzheimer’s Powerhouses

GE Healthcare and Johnson & Johnson are teaming up in a research pact that pairs one of the most advanced imaging agents for Alzheimer’s disease with one of the most advanced drugs being tested to fight it.

The companies said on Wednesday the deal is meant to advance efforts to find biological signals to detect Alzheimer’s disease at an earlier stage, when experts think drugs will have the best chance of making a difference.

New Test May Help Patients With RA Avoid Useless Treatment

A network of rheumatology practitioners is teaming up with several pharmaceutical companies to evaluate a new biomarker screening test that might help identify patients with rheumatoid arthritis (RA) who are unlikely to benefit from treatment with antitumor necrosis factor-alpha (anti-TNF) agents. This could help clinicians avoid exposing individual patients to adverse effects from drugs unlikely to be effective, reduce healthcare costs, and quickly identify patients who would be candidates for other regimens or for clinical trials of new agents.